about
Monovalency unleashes the full therapeutic potential of the DN-30 anti-Met antibodyTargeting the oncogenic Met receptor by antibodies and gene therapy.Rebound Effects Caused by Withdrawal of MET Kinase Inhibitor Are Quenched by a MET Therapeutic Antibody.Cardiac concentric hypertrophy promoted by activated Met receptor is mitigated in vivo by inhibition of Erk1,2 signalling with Pimasertib.Inhibition of ligand-independent constitutive activation of the Met oncogenic receptor by the engineered chemically-modified antibody DN30.Targeted therapy by gene transfer of a monovalent antibody fragment against the Met oncogenic receptor.T cell receptor (TCR) gene transfer with lentiviral vectors allows efficient redirection of tumor specificity in naive and memory T cells without prior stimulation of endogenous TCR.Dual Constant Domain-Fab: A novel strategy to improve half-life and potency of a Met therapeutic antibody.Quiescent neuronal progenitors are activated in the juvenile guinea pig lateral striatum and give rise to transient neurons.Anti-Differentiation Effect of Oncogenic Met Receptor in Terminally-Differentiated Myotubes.CD44v6 as innovative sarcoma target for CAR-redirected CIK cells.MET/HGF Co-Targeting in Pancreatic Cancer: A Tool to Provide Insight into the Tumor/Stroma CrosstalkTargeting the MET oncogene by concomitant inhibition of receptor and ligand via an antibody-"decoy" strategyMet inhibition revokes IFNγ-induction of PD-1 ligands in MET-amplified tumours
P50
Q34285473-8BFD37EE-510B-49B9-B25A-E2C682CB60EBQ38216590-DDEE36C3-8D3B-4D9D-BF4D-A05B95EBE1C9Q38760606-6B04E6A4-C07F-41FD-ADDD-688B72982ABAQ38790312-DD30568C-280D-4660-B8F4-5595F16E84FDQ38859217-1C498974-6A8A-4457-A4C0-FE86242EBE48Q39098665-41158079-4DAD-4475-97FD-14CEA12FE1CBQ39813094-D3E75772-774E-45E3-BF36-4797F0948B9DQ42282846-AD2E160B-0523-4DCE-A82E-D08A79692155Q48478287-1E4E4619-F819-4FCE-B7F9-564D46692AFAQ50985099-2D86B2F1-43C9-43E2-985A-9545CB3C69CFQ52714322-439C7002-A5BE-49BE-8207-8974EEF02304Q60909538-A4C3F82C-71B8-4C08-9330-23AB3D9E50B6Q88467955-129DCD24-D89A-4AF3-B13C-FCE6F780B0E4Q91361655-3F06B93B-BB06-421E-B249-C600CBED98C4
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Elisa Vigna
@en
Elisa Vigna
@nl
type
label
Elisa Vigna
@en
Elisa Vigna
@nl
prefLabel
Elisa Vigna
@en
Elisa Vigna
@nl
P31
P496
0000-0001-9787-5732